Valuation: Becton, Dickinson and Company

Market Cap 57.91B 51.94B 47.86B 43.47B 82.27B 5,430B 84.56B 573B 228B 2,909B 217B 213B 9,196B P/E 2026
43.8x
P/E 2027 * 28.9x
Enterprise Value 73.8B 66.18B 60.99B 55.39B 105B 6,919B 108B 730B 291B 3,707B 277B 271B 11,719B EV / Sales 2026
2.51x
EV / Sales 2027 * 3.66x
Free-Float
73.18%
Yield 2026 *
1.97%
Yield 2027 * 1.97%
1 day-1.23%
1 week+7.29%
Current month+7.44%
1 month+15.71%
3 months+18.36%
6 months+42.28%
Current year+9.55%
1 week 206.5
Extreme 206.5
216.74
1 month 184.32
Extreme 184.32
216.74
Current year 140.11
Extreme 140.11
216.74
1 year 140.11
Extreme 140.11
216.74
3 years 140.11
Extreme 140.11
251.98
5 years 140.11
Extreme 140.11
287.32
10 years 140.11
Extreme 140.11
287.32
Manager TitleAgeSince
Chief Executive Officer 53 2020-01-27
Director of Finance/CFO 44 2025-12-04
Chief Tech/Sci/R&D Officer 56 2023-12-03
Director TitleAgeSince
Director/Board Member 75 2002-09-23
Director/Board Member 71 2010-07-25
Chairman 53 2021-04-27
Date Insider Type Main position Quantity % Market Cap. Importance
10/26/26 Sell

Executive/Senior Manager

-76 0.0000%
9/28/26 Sell

Executive/Senior Manager

-76 0.0000%
9/2/26 Tax

Chief Financial Officer

-190 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
-1.23%+7.29%+17.05%-9.39% 58.63B
-0.05%+0.97%-12.26%+17.55% 191B
-1.17%+2.74%+9.64%+43.73% 126B
-0.44%+4.42%-8.66%+18.52% 124B
-1.57%+1.82%-39.83%+7.26% 98.14B
+0.85%+2.41%-4.37%+76.50% 65.98B
-1.42%+3.66%-1.82%+62.49% 55.67B
+0.81%-2.74%-4.75%+54.09% 48.78B
+1.08%+3.41%+4.00%-4.71% 36.03B
+0.49%+20.01% - - 35.77B
Average -0.25%+4.22%-4.56%+29.56% 84B
Weighted average by Cap. -0.42%+3.30%-6.95%+27.74%

Financials

2026 2027 *
Net sales 19.29B 17.3B 15.94B 14.48B 27.4B 1,809B 28.17B 191B 76.06B 969B 72.39B 70.86B 3,063B 19.8B 17.75B 16.36B 14.86B 28.12B 1,856B 28.91B 196B 78.05B 994B 74.29B 72.72B 3,144B
Net income 1.41B 1.26B 1.16B 1.06B 2B 132B 2.05B 13.92B 5.54B 70.64B 5.28B 5.17B 223B 2.01B 1.8B 1.66B 1.51B 2.86B 188B 2.94B 19.89B 7.93B 101B 7.54B 7.38B 319B
Net Debt 15.88B 14.25B 13.13B 11.92B 22.57B 1,489B 23.2B 157B 62.63B 798B 59.61B 58.35B 2,523B 14.63B 13.12B 12.09B 10.98B 20.78B 1,371B 21.36B 145B 57.67B 735B 54.9B 53.73B 2,323B
Projected Income Statement - Annual - Becton, Dickinson and Company
Logo Becton, Dickinson and Company
Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical management systems (52.4%): medication delivery systems, pharmaceutical systems, advanced patient monitoring systems, etc.; - interventional medical equipment (23.9%): surgical instruments, urological care products, etc.; - diagnostic materials and clinical research and development tools (23.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, tools for studying genes and culturing cells, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (58.6%), Europe/Middle East/Africa (21.6%), Asia (14.2%) and other (5.6%).
Employees
60,000
Date Price Change Volume
26-11-10 $212.61 -1.23% 1,790,252
26-11-09 $215.25 +1.59% 2,039,094
26-11-06 $211.88 -0.78% 2,172,611
26-11-05 $213.55 +2.08% 3,991,906
26-11-04 $209.19 +5.56% 4,460,588
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - Becton, Dickinson and Company
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
212.61USD
Average target price
226.14USD
Spread / Average Target
+6.37%